Mereo BioPharma Group plc

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Rok finansowy 2016 2016 2016 2016 2017 2017 2017 2017 2018 2018 2018 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2016-03-31 2016-06-30 2016-09-30 2016-12-31 2017-03-31 2017-06-30 2017-09-30 2017-12-31 2018-03-31 2018-06-30 2018-09-30 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 25 51 0 0 0 0 1 1 4 9 1 0 0 0 0 0 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% inf% inf% 0.0% -98.16% -100.00% 118.7% inf% 670.8% inf% -20.97% -56.60% -100.00% -100.00% -100.00% -100.00% 0.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -inf% 0.0% -inf% 0.0% -inf% 0.0% -inf% 50.3% 49.5% 50.0% -inf% 50.0% -inf% 50.0% 138.8% 65.6% 59.9% 67.6% 39.9% -inf% -inf% 0.0% 0.0% 0.0%
Koszty i Wydatki (mln) 12 11 11 10 17 18 13 13 13 12 11 11 11 24 12 27 77 -7 24 27 16 51 4 29 13 28 9 26 9 25 7 7 10 13 9 15 0
EBIT (mln) -13 -12 -12 -11 -17 -17 -13 -13 -11 -10 -12 -12 -12 -24 -12 -27 -10 -7 -13 -27 -0 -0 -14 -29 -14 -28 -13 -26 -5 -16 -6 -6 -10 -13 -9 -15 -11
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 26.9% 42.9% 8.7% 13.7% -33.25% -39.60% -3.47% -6.30% 10.9% 128.5% 2.5% 123.1% -15.41% -69.95% 7.8% 2.5% -98.64% -96.04% 3.7% 4.8% 10088.0% 9870.9% -8.98% -10.54% -65.41% -44.24% -51.51% -77.72% 99.8% -18.65% 52.0% 168.3% 13.2%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -0.56% -0.56% -4526.66% 0.0% -3098.02% 0.0% -1883.56% -3071.05% -139.02% -179.19% -1155.81% -1576.50% 0.0% 0.0% 0.0% nan nan
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 1 1 1 1 1 1 2 2 2 0 2 2 1 1 1 1 1 0 1 1 0 1 0 0 1 1 1 1 1
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 2 0 1 1 1 0 0 0 0 0 0 -0
Amortyzacja (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 1 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0
EBITDA (mln) -13 -12 -12 -11 -17 -17 -13 -13 -11 -10 -12 -12 -12 -23 -12 -26 -10 -10 -13 -27 0 0 -14 -27 -14 -28 -14 -25 -11 -0 -7 -7 -9 -12 -9 -6 -11
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.2% -4516.18% 0.0% -3036.09% 0.0% -1879.27% -3027.43% -138.08% -173.53% -1118.61% -1524.29% 0.0% 0.0% 0.0% nan nan
NOPLAT (mln) -12 -11 -11 -10 -17 -18 -13 -13 -14 -13 -12 -11 -12 -24 -14 -28 -78 -63 -26 -53 8 15 2 5 -13 -26 -9 -19 -6 -15 -6 -6 -9 -12 -15 -7 -13
Podatek (mln) 2 1 2 2 3 3 2 2 2 2 2 2 2 -3 2 -5 1 -1 1 -2 1 -2 2 4 0 -1 0 -1 0 -1 0 0 -0 0 0 0 0
Zysk Netto (mln) -11 -10 -9 -8 -14 -15 -11 -11 -12 -11 -10 -10 -11 -21 -11 -23 -77 -62 -25 -51 8 17 0 1 -13 -25 -9 -18 -6 -14 -7 -6 -9 -12 -15 -7 -13
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 34.3% 51.3% 21.5% 28.7% -16.36% -24.31% -8.88% -11.54% -11.35% 87.2% 16.8% 144.5% 633.2% 196.9% 119.8% 117.3% 110.8% 126.9% 101.7% 101.7% -251.03% -247.93% -2277.49% -2134.47% -56.17% -45.23% -29.81% -65.76% 62.3% -9.90% 128.7% 16.5% 44.0%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 33.2% 33.2% 139.1% 0.0% -2721.31% 0.0% -1384.54% -2122.45% -154.74% -154.74% -1229.72% -1674.49% 0.0% 0.0% 0.0% nan nan
EPS -2.13 -1.96 -0.68 -0.65 -1.06 -1.1 -0.76 -0.77 -0.84 -0.79 -0.69 -0.67 -0.72 -1.42 -0.54 -1.21 -3.29 -0.11 -0.22 -0.75 0.0144 0.17 0.14 0.0074 -0.11 -0.0425 -0.0163 -0.0283 -0.01 -0.0247 -0.0095 -0.0087 -0.0128 -0.0861 -0.0974 -0.0093 -0.1
EPS (rozwodnione) -2.13 -1.96 -0.68 -0.65 -1.06 -1.1 -0.76 -0.77 -0.84 -0.79 -0.69 -0.67 -0.72 -1.42 -0.54 -1.21 -3.29 -0.11 -0.22 -0.75 0.0767 0.15 0.0038 0.0074 -0.11 -0.0425 -0.015 -0.0283 -0.0088 -0.0217 -0.0095 -0.0087 -0.0128 -0.0861 -0.0195 -0.0093 -0.1
Ilośc akcji (mln) 5 5 13 13 13 13 14 14 14 14 14 14 15 15 21 19 24 585 112 68 577 99 3 117 117 584 572 624 552 552 692 692 700 142 154 755 157
Ważona ilośc akcji (mln) 5 5 13 13 13 13 14 14 14 14 14 14 15 15 21 19 24 585 112 68 109 109 114 117 117 584 623 624 627 627 692 692 700 142 770 755 157
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD